{
  "ticker": "JNJ",
  "target_date": "2025-03-10",
  "actual_date": "2025-03-10",
  "collected_at": "2025-12-08T11:29:48.272672",
  "price": {
    "open": 163.81,
    "high": 166.17,
    "low": 163.39,
    "close": 164.02154541015625,
    "volume": 17559000,
    "change_1d_pct": 0.61,
    "change_7d_pct": 2.42,
    "change_30d_pct": 15.14
  },
  "technicals": {
    "rsi_14": 77.57,
    "sma_20": 157.83,
    "sma_50": 149.08,
    "macd": 4.168,
    "macd_signal": 4.06,
    "macd_histogram": 0.108,
    "bb_upper": 167.83,
    "bb_lower": 147.83,
    "price_vs_sma20_pct": 3.92,
    "price_vs_sma50_pct": 10.02,
    "volume_ratio": 1.79
  },
  "fundamentals": {
    "market_cap": 488665284608,
    "pe_ratio": 19.577703,
    "forward_pe": 19.134434,
    "price_to_book": 6.1560993,
    "price_to_sales": 5.302991,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.4,
    "pct_from_52w_low": 44.17
  },
  "macro": {
    "spy": {
      "price": 555.71,
      "change_1d_pct": -2.66,
      "change_7d_pct": -5.65
    },
    "vix": {
      "level": 27.86,
      "signal": "HIGH_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.21
    },
    "dollar_index": {
      "level": 103.91
    },
    "gold": {
      "price": 2891.0
    },
    "regime": "BEAR_HIGH_VOL"
  },
  "news": [
    {
      "headline": "Are High-Yield Dividend Stocks Best for Income-Focused Investors?",
      "source": "Yahoo",
      "datetime": 1741647840,
      "summary": "Dividends come with many clear benefits, including a passive income stream and a shield against drawdowns in other positions.",
      "url": "https://finnhub.io/api/news?id=cdf431b26e840376c1ed4a347b7e1e05d545e53f81166debba7e988880a82b79"
    },
    {
      "headline": "Johnson & Johnson - Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis",
      "source": "Finnhub",
      "datetime": 1741610360,
      "summary": "SPRING HOUSE - Johnson & Johnson today announced new icotrokinra data from its comprehensive Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis seeking...",
      "url": "https://finnhub.io/api/news?id=3263c10710231cbb6e510e225c0f7e187192b181425afcabeb46997b9c6a3312"
    },
    {
      "headline": "Genmab Shares Fall After J&J Drops Blood-Cancer Treatment Option",
      "source": "MarketWatch",
      "datetime": 1741604460,
      "summary": "Genmab Shares Fall After J&J Drops Blood-Cancer Treatment Option",
      "url": "https://finnhub.io/api/news?id=951910a318b37d2a9dc926640a43045d151550e30e14b359ca9b482011190688"
    },
    {
      "headline": "Genmab Stops Blood Cancer Treatment Development After J&J Won't License It",
      "source": "MarketWatch",
      "datetime": 1741603380,
      "summary": "Genmab Stops Blood Cancer Treatment Development After J&J Won't License It",
      "url": "https://finnhub.io/api/news?id=d6579e85e922701d5f72dc097b5e0086e106434b9f454af1bbdbc2d21020e599"
    },
    {
      "headline": "Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out",
      "source": "DowJones",
      "datetime": 1741601986,
      "summary": "Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out",
      "url": "https://finnhub.io/api/news?id=a55d7493fb58c6cf6d7bc37bd29ce2e81811d28363bf7b4f62e782336c9cd1f8"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-06",
      "description": "xslF345X05/wk-form4_1741297319.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000095/xslF345X05/wk-form4_1741297319.xml"
    },
    {
      "form": "4",
      "date": "2025-03-06",
      "description": "xslF345X05/wk-form4_1741297124.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000093/xslF345X05/wk-form4_1741297124.xml"
    },
    {
      "form": "4",
      "date": "2025-02-26",
      "description": "xslF345X05/wk-form4_1740613359.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000086/xslF345X05/wk-form4_1740613359.xml"
    },
    {
      "form": "8-K",
      "date": "2025-02-26",
      "description": "d863514d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525036773/d863514d8k.htm"
    },
    {
      "form": "8-K",
      "date": "2025-02-20",
      "description": "d866332d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525030851/d866332d8k.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}